Physician profile
Luis G Ramirez
NPI 1346483518
$3,565.36
in general payments reported to CMS, 2019-2025
12 companies · $2,030 in 2025
The $2,030 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $858 · 2020: $49.41 · 2022: $44.11 · 2023: $502 · 2024: $82.02 · 2025: $2,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $1,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,114.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $1,554.51 | 2024-2025 | Catalyst Csr Shoulder System |
| Arthrex, INC. | $910.00 | 2019-2023 | |
| Stryker Corporation | $397.29 | 2019-2025 | Gamma, T2 Alpha, Hoffmann |
| Biedermann Motech, INC. | $289.29 | 2025 | Distal Humerus Plate |
| Medical Device Business Services, INC. | $112.12 | 2019 | |
| Depuy Synthes Sales INC. | $80.21 | 2022-2025 | Tfn-Advance |
| Axogen | $69.50 | 2025 | |
| Johnson & Johnson Health Care Systems INC. | $49.41 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $48.28 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $27.24 | 2025 | |
| Solventum Corporation | $14.19 | 2024 | Activ.A.C., Kerramax Care, Promogran Prisma |
| Bioventus LLC | $13.32 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.